Lijie Rong
- Immunology top 10%
- Immune Response and Inflammation 2
- Immune cells in cancer 2
- Inflammation biomarkers and pathways 1
-
- CAR-T cell therapy research 3
-
- Epigenetics and DNA Methylation 3
- Angiogenesis and VEGF in Cancer 2
-
- Bladder and Urothelial Cancer Treatments 3
-
- Cell Adhesion Molecules Research 2
- Cited by
- ImmunologyOncologyCancer Research
- Journals
- Cancer Research (3 papers)Cellular and Molecular Immunology (1 paper)Protein & Cell (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Lijie Rong
12 papers receiving 416 citations
Peers
Comparison fields: 5 of 55
- Immunology 277
- Oncology 148
- Cancer Research 45
- Hematology 22
- Molecular Biology 134
Countries citing papers authored by Lijie Rong
This map shows the geographic impact of Lijie Rong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijie Rong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijie Rong more than expected).
Fields of papers citing papers by Lijie Rong
This network shows the impact of papers produced by Lijie Rong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijie Rong. The network helps show where Lijie Rong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lijie Rong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2022 | 9 | |
| 4 | 2021 | 16 | |
| 5 | 2019 | 40 | |
| 6 | 2017 | 12 | |
| 7 | 2017 | 1 | |
| 8 | 2017 | 5 | |
| 9 | 2014 | 30 | |
| 10 | 2013 | 3 | |
| 11 | 2012 | 296 | |
| 12 | 2011 | 5 |
About Lijie Rong
Lijie Rong is a scholar working on Immunology and Allergy, Immunology and Biotechnology, having authored 12 papers that have together received 419 indexed citations. Recurring topics across this work include CAR-T cell therapy research (3 papers), Bladder and Urothelial Cancer Treatments (3 papers), Epigenetics and DNA Methylation (3 papers), Immune Response and Inflammation (2 papers), Immune cells in cancer (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Cell Adhesion Molecules Research (2 papers) and Inflammation biomarkers and pathways (1 paper). The work is most often cited by research in Immunology (277 citations), Oncology (148 citations) and Cancer Research (45 citations). Lijie Rong has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Jingjing Deng, Zhihai Qin, Xiaoman Liu, Uta Syrbe, Xia Xu, Ulrike Erben, Peihua Wu, Joachim Sieper, Xiao Li and Xueqiang Zhao. Their work appears in journals such as Cancer Research, Cellular and Molecular Immunology, Protein & Cell, The Journal of Urology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.